Estimating average annual per cent change in trend analysis

Abstract

Trends in incidence or mortality rates over a specified time interval are usually described by the conventional annual per cent change (cAPC), under the assumption of a constant rate of change. When this assumption does not hold over the entire time interval, the trend may be characterized using the annual per cent changes from segmented analysis (sAPCs). This approach assumes that the change in rates is constant over each time partition defined by the transition points, but varies among different time partitions. Different groups (e.g. racial subgroups), however, may have different transition points and thus different time partitions over which they have constant rates of change, making comparison of sAPCs problematic across groups over a common time interval of interest (e.g. the past 10 years). We propose a new measure, the average annual per cent change (AAPC), which uses sAPCs to summarize and compare trends for a specific time period. The advantage of the proposed AAPC is that it takes into account the trend transitions, whereas cAPC does not and can lead to erroneous conclusions. In addition, when the trend is constant over the entire time interval of interest, the AAPC has the advantage of reducing to both cAPC and sAPC. Moreover, because the estimated AAPC is based on the segmented analysis over the entire data series, any selected subinterval within a single time partition will yield the same AAPC estimate—that is it will be equal to the estimated sAPC for that time partition. The cAPC, however, is re‐estimated using data only from that selected subinterval; thus, its estimate may be sensitive to the subinterval selected. The AAPC estimation has been incorporated into the segmented regression (free) software Joinpoint, which is used by many registries throughout the world for characterizing trends in cancer rates. Copyright © 2009 John Wiley & Sons, Ltd.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 16

1. 1.

   Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 2004;101:3-27.

   Not in our library10.1002/cncr.20288

2. 2.

   Ries LAG, Eisner MP, Hankey BF, Miller BA, Clegg LX, Mariotto A, Feuer EJ, Edwards BK. 2004.

   Not in our library

3. 3.

   Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH, Heiss G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. New England Journal of Medicine. 1998;339:861-867.

   Not in our library10.1056/nejm199809243391301

4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

5. 5.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

6. 6.

   Clayton D, Hills M. Statistical Models in Epidemiology. 1993;80-81.

   Not in our library

7. 7.

   Casella G, Berger RL. Statistical Inference. 1990;330.

   Not in our library

8. 8.

   Oehlert GW. A note on the delta method. The American Statistician. 1992;46:27-29.

   Not in our library

9. 9.

   Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey B. Impact of reporting delay and reporting error on cancer incidence rates and trends. Journal of the National Cancer Institute. 2002;94:1537-1545.

   Not in our library10.1093/jnci/94.20.1537

10. 10.

    Midthune DN, Fay MP, Clegg LX, Feuer EJ. Modeling reporting delays and reporting corrections in cancer registry data. Journal of the American Statistical Association. 2005;100:61-70.

    Not in our library

11. 11.

    Lerman PM. Fitting segmented regression models by grid search. Applied Statistics. 1980;29:77-84.

    Not in our library

12. 12.

    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine. 2000;19:335-351.

    Not in our library10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z

13. 13.

    Kim HJ, Fay MP, Yu B, Barret MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics. 2004;60:1005-1014.

    Not in our library10.1111/j.0006-341x.2004.00256.x

14. 14.

    Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107:1711-1742.

    Not in our library10.1002/cncr.22193

15. 15.

    Ries LAG, Eisner MP, Hankey BF, Miler BA, Clegg LX, Mariotto A, Feuer EJ, Edwards BK. SEER Cancer Statistics Review, 1975–2002. 2005.

    Not in our library

16. 16.

    Brillinger DR. The natural variability of vital rates and associated statistics. Biometrics. 1986;42:693-734.

    Not in our library

Cited by papers we hold 21

• Global trends and inequalities in eye cancer burden: a comprehensive analysis based on the global burden of disease study · 2025
  Not checked
• Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status · 2024
  No notice
• Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019 · 2022
  Not checked
• Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study · 2022
  No notice
• Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990–2019: results from the global burden of disease study 2019 · 2022
  Corrected
• Urban-rural disparity in cancer mortality and changing trend in Tianjin, China, during 1999 and 2016 · 2021
  Not checked
• Global Incidence and Mortality of Gastric Cancer, 1980-2018 · 2021
  No notice
• Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries · 2021
  No notice
• Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States · 2021
  No notice
• Global incidence and mortality of breast cancer: a trend analysis · 2021
  No notice
• Global trends and gaps in research related to latent tuberculosis infection · 2020
  Not checked
• Trends in Alcohol-Induced Deaths in the United States, 2000-2016 · 2020
  No notice
• An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study · 2020
  Not checked
• Stroke Mortality Attributable to Low Fruit Intake in China: A Joinpoint and Age-Period-Cohort Analysis · 2020
  Not checked
• Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025 · 2019
  No notice
• Changing epidemiological patterns of HIV and AIDS in China in the post-SARS era identified by the nationwide surveillance system · 2018
  Not checked
• The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection · 2018
  No notice
• Incidence and mortality of lung cancer: global trends and association with socioeconomic status · 2017
  No notice
• Global temporal patterns of pancreatic cancer and association with socioeconomic development · 2017
  No notice
• International incidence and mortality trends of liver cancer: a global profile · 2017
  No notice

and 1 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.